Skip to content

Placenta Perfusion and Sufficiency Study

Placenta Perfusion and Sufficiency Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06042348
Acronym
P2SS
Enrollment
10
Registered
2023-09-18
Start date
2023-09-15
Completion date
2024-01-31
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female, Human, Placenta Diseases, Diagnosis, Pregnancy Related

Keywords

Placenta, Human, Pregnancy, Early pregnancy, Hypertension disorders, Uterus, Uterine artery, Uterine vein, Placental circulation, Placenta physiology, Netherlands, Placenta development

Brief summary

Ultrasonography will be used to determine the total blood flow to and from the uterus. This is done by measuring the blood vessels coming from and going to the uterus. This wil hopefully prove viable and open the possibility to further research in the clinical relevance of these measurements.

Detailed description

This prospective pilot study takes place between 14- and 16-weeks' gestation (GA14 to 16 weeks). This is a feasibility study, as the perfusion measurements have not yet been performed this early in pregnancy. First the feasibility is assessed, before conducting a full-scale research project. The study will take place in a tertiary care obstetric centre, Máxima Medical Center, in Veldhoven The Netherlands. Measurements will be done at the out patient clinic of obstetrics. Duration of the study is 2 months. This gives ample time for recruitment of the subjects. Recruitment will take place at the outpatient clinic of Máxima Medisch Centrum in Veldhoven. Women with singleton pregnancies coming for their 11-12 weeks' gestational ultrasound, where the pregnancy is dated, will be given a patient information folder in either Dutch or English and asked if the researcher can contact them. Participation is completely on voluntary basis. Patients will be called in the next days by the researcher to answer additional questions and to ask if patients are willing to participate. Contact information of the researchers will be available on the folder in case of questions. Upon inclusion, the patients will be scheduled for a visit to perform all relevant measurements, henceforth referred to as 'measurement day' (MD) which is to take place between 14- and 16-weeks' gestation. The patient, henceforth to be referred to as participant, will be asked to rest for 5 minutes in a supine position. After 5 minutes of rest the blood pressure of the right arm will be measured, three times using the auto-sphygmomanometer. The three measurements will then be used to calculate the average systolic and diastolic blood pressures. After measurement of blood pressure, the ultrasound scan will be performed. The uterine and placental vessels will be measured according to the standard operating procedure attached to this document. All vessels will be measured 3 times during the ultrasound scan.

Interventions

DIAGNOSTIC_TESTTrans abdominal ultrasound

Ultra sound of the uterus and uterine blood vessels

Sponsors

Maxima Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 18 years * Between 14-16 weeks gestation on measurement day * Placenta anterior * BMI \< 30kg/m2 * Ability to give consent * Adequate mastery of the Dutch or English languages

Exclusion criteria

* Non-intact pregnancy at 13 week's gestational echo. * Vanishing twin * Multiple gestations * Congenital or anatomical anomalies at 13 weeks' gestational echo.

Design outcomes

Primary

MeasureTime frameDescription
Uterine blood vessel flowThrough study completion, an average of 1 yearThe feasibility of measuring placenta perfusion between 14-16 weeks of gestation

Secondary

MeasureTime frameDescription
uterine vessel differencesThrough study completion, an average of 1 yearTo assess whether there are differences in measurements between the two umbilical arteries
Relation between uterine vesselsThrough study completion, an average of 1 yearTo determine whether a relation between the uterine artery and vein flow exists

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026